Stocktoria
BridgeBio Pharma, Inc. BBIO
BridgeBio Pharma, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | 14,393,934 | $1.1B | 7.39% |
| BlackRock Finance, Inc. | 12,448,272 | $315.3M | 6.39% |
| CITADEL ADVISORS LLC | 3,390,240 | $251.8M | 1.74% |
| TWO SIGMA INVESTMENTS, LP | 3,120,631 | $231.7M | 1.6% |
| D. E. Shaw & Co., Inc. | 2,545,486 | $189.0M | 1.31% |
| MILLENNIUM MANAGEMENT LLC | 633,283 | $47.0M | 0.33% |
| RENAISSANCE TECHNOLOGIES LLC | 365,772 | $27.2M | 0.19% |
| Bridgewater Associates, LP | 259,459 | $19.3M | 0.13% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.